Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma
Clinical trial NCT02595242 · WITHDRAWN
Trial details
- NCT number
- NCT02595242
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.